skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Summary

Query: Party Name contains all words: EYEPOINT PHARMACEUTICALS US, INC.
Number of results: 11

Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
97724847
11/30/2023
EyePoint Pharmaceuticals US, Inc.
Mark: RETIVU S#:97724847
Eli Lilly and Company
97724835
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAMAC S#:97724835
Novartis AG
97767088
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVUE S#:97767088
Novartis AG
98048453
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURVUE S#:98048453
Novartis AG
98048464
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURVIEW S#:98048464
Novartis AG
98073717
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVYU S#:98073717
Novartis AG
97724740
11/28/2023
EyePoint Pharmaceuticals US, Inc.
Mark: DURAVU S#:97724740
Novartis AG
97724877
11/27/2023
EyePoint Pharmaceuticals US, Inc.
Mark: RYVIZ S#:97724877
JOHNSON & JOHNSON
98048432
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark: OPVUE S#:98048432
Indivior Inc.
97724775
11/13/2023
EyePoint Pharmaceuticals US, Inc.
Mark: OPVU S#:97724775
Indivior Inc.
88167946
04/18/2019
EyePoint Pharmaceuticals US, Inc.
Mark: YUTIQ S#:88167946
Merck Sharp & Dohme Corp.

Results as of 02/21/2024 01:23 AMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY